https://www.selleckchem.com/pr....oducts/liproxstatin-
Phase 3 trials in sPTL.. · There were no safety concerns with retosiban treatment.. · Slow recruitment led to termination of the Phase 3 trials.. · There is a need for an effective and safe treatment for sPTL.. · ARIOS was a follow-up study of two Phase 3 trials in sPTL.. · There were no safety concerns with retosiban treatment.. · Slow recruitment led to termination of the Phase 3 trials.. The study aimed to explore physician views on whether extremely early newborns will have an acceptable quality of life (QOL), and if these v
Like
Comment
Share
